Sen. Grassley Hints At GOP’s Willingness To Work With Democrats On Health Law Changes
The change in tone by the influential Republican may signal changing battle lines on the Affordable Care Act.
The independent source for health policy research, polling, and news.
36,061 - 36,080 of 112,606 Results
The change in tone by the influential Republican may signal changing battle lines on the Affordable Care Act.
Biotechs see patients and advocacy groups as a resource to raise awareness and champion drugs to the Food and Drug Administration. A recent example is Sarepta's Duchenne medication which patient organizations helped move through the agency.
More than eight in 10 Americans favor allowing the federal government to negotiate with drugmakers to get lower prices on medications for people on Medicare, among other regulations. A separate poll finds that the public holds the pharmaceutical industry responsible for rising drug prices, but some critics say Congress should shoulder some blame.
In the letter to the Justice Department, senators say the company "may have knowingly misclassified EpiPens, potentially in violation of the False Claims Act and other statutes."
The son of a man who died of the virus contracted it after sitting by his father's bedside, touching his skin and wiping his eyes. Meanwhile, the Centers for Disease Control and Prevention responds to a whistleblower's claims that it is not using the most effective test for Zika.
After House leaders reach an agreement over the Flint water crisis funds, Congress averts a government shutdown by passing a bill that includes $1.1 billion for the fight against Zika.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical drug pricing.
Outlets report on health news from California, Minnesota, the District of Columbia, Florida, South Carolina, Wisconsin, New York, Massachusetts and Colorado.
The day-long session will explore whether the state should expand Medicaid to cover the estimated 78,000 residents who don't qualify for Medicaid or for subsidies to help buy insurance on the health marketplace. Also, Alaska officials and Xerox have settled a dispute over the complaints that the company, which set up a payment system for the state, was slow to reimburse doctors and other health providers.
Polls have shown the "yes" side leading in most states with a marijuana-related ballot measure.
In other state hospital news, Georgia's rural hospitals are hopeful about tax credit program, a Massachusetts watchdog agency raises a red flag about Boston Children's planned expansion and a surprise inspection of a Pennsylvania hospital finds shortcomings.
In other news related to head injuries, an analysis of regional insurance claims shows that concussion rates among young boys and girls are on the rise in many states.
Among the possible causes cited by suicide experts is a decline in the use of psychiatric medicines and the rise of cyberbullying. In other public health news, 92 percent of the world is breathing bad air, the Americas are declared free of endemic measles, C. diff is on the rise and a look at a mysterious lymphatic disease.
Police departments have started releasing photos and videos of parents who overdose in front of their children. Some say they're what's needed to finally get people outraged enough to act on the crisis, but others say it's demoralizing and only makes it harder for those who want to get help.
One expert weighs in on that and other questions about flu vaccine science.
The controversial procedure replaces the mother's faulty mitochondria with donor mitochondria to produce a healthy baby while preserving the vast majority of its mother's DNA.
Advocates envision a world in which technology allows office visits to be transcribed in real time or compares patient records to determine a diagnosis. But, in a situation where a glitch could have fatal consequences, moving away from human scribes could be a grave mistake.
© 2026 KFF